prikaz prve stranice dokumenta High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
  Preuzmi
PDF 522.46 KB
Znanstveni rad - Izvorni znanstveni rad
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
Acta Diabetologica, 56 (2019), 9; 1045-1049. https://doi.org/10.1007/s00592-019-01346-1
Campbell, Matthew D.; Babic, Drazen; Bolcina, Uros; Smirčić-Duvnjak, Lea; Tankova, Tsvetalina; Mitrakou, Asimina; Kempler, Peter; Janez, Andrej

Citirajte ovaj rad

Campbell, M. D., Babic, D., Bolcina, U., Smirčić Duvnjak, L., Tankova, T., Mitrakou, A. ... Janez, A. (2019). High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study. Acta Diabetologica, 56. (9), 1045-1049. doi: 10.1007/s00592-019-01346-1

Campbell, Matthew D., et al. "High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study." Acta Diabetologica, vol. 56, br. 9, 2019, str. 1045-1049. https://doi.org/10.1007/s00592-019-01346-1

Campbell, Matthew D., Drazen Babic, Uros Bolcina, Lea Smirčić Duvnjak, Tsvetalina Tankova, Asimina Mitrakou, Peter Kempler i Andrej Janez. "High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study." Acta Diabetologica 56, br. 9 (2019): 1045-1049. https://doi.org/10.1007/s00592-019-01346-1

Campbell, M. D., et al. (2019) 'High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study', Acta Diabetologica, 56(9), str. 1045-1049. doi: 10.1007/s00592-019-01346-1

Campbell MD, Babic D, Bolcina U, Smirčić Duvnjak L, Tankova T, Mitrakou A, i sur.. High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study. Acta Diabetologica [Internet]. 09.2019. [pristupljeno 31.01.2025.];56(9):1045-1049. doi: 10.1007/s00592-019-01346-1

M. D. Campbell, et al., "High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study", Acta Diabetologica, vol. 56, br. 9, str. 1045-1049, Rujan 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:262710. [Citirano: 31.01.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:262710
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
AutorMatthew D. Campbell
AutorDrazen Babic
AutorUros Bolcina
AutorLea Smirčić-Duvnjak
AutorTsvetalina Tankova
AutorAsimina Mitrakou
AutorPeter Kempler
AutorAndrej Janez
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Aims: Little is known regarding initiation of insulin therapy in type 2 diabetes (T2D) in Central and South-Eastern European countries. Therefore, we conducted a survey to characterise the prescribing practices of specialist diabetes healthcare professionals in this region and assessed factors that influence clinical decision-making regarding insulin initiation in T2D. ------ Methods: A cross-sectional survey sampled 211 specialist diabetes healthcare prescribers from five Central and South-Eastern European countries (Bulgaria, Croatia, Greece, Hungary, and Slovenia). A structured questionnaire was developed which surveyed current clinical practices and influencing factors, barriers to insulin initiation, and combination therapy prescribing preferences. ----- Result: Only 9.4% (20 of out of 211 respondents) of healthcare professionals would initiate insulin therapy in T2D patients at the recommended HbA1c threshold of 7-7.9% [53-63 mmol/mol]. Large regional differences were evident in insulin initiation thresholds (≥ 9.0% [≥ 75 mmol/mol]: Bulgaria 80.8% vs. Slovenia 13.3%). Psychological distress was recorded as the major barrier to insulin initiation. Health insurance regulations were ranked more important than personal clinical experience and clinical guidelines in clinical decision-making. Information from peers was more influential than manufacturer information, clinical experience, and continuous medical education, respectively, for insulin initiation. ----- Conclusions: Despite large regional variation, there is widespread delay of insulin initiation from specialist diabetes healthcare professionals in Central and South-Eastern Europe.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaActa Diabetologica
Brojčani podacivol. 56, br. 9, str. 1045-1049
p-ISSN0940-5429
DOIhttps://doi.org/10.1007/s00592-019-01346-1
URN:NBNurn:nbn:hr:105:262710
Datum objave publikacije2019-09
URL dokumentahttp://doi.org/10.1007/s00592-019-01346-1
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 10:34:45